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I 991 3 Elevation of Plasma Llpld Peroxldatlon Producta In Patlenta Wlth Uncltabls Coronary Artery Dlnoaae 
K. Koatnar, P, Yang, D. Qlognr, G. Maurer, K. Hubof. Dep~lrmenf of 
Ci~rdlo/ogfi Unbmlfy of Vbnm, Auslrh 
Thoro la lncreaslna evlda~lco lhul okldallvo~y modified IlpoprotekIa play a key 
role In the palhogananla of athoroaclerosle and lhat antlaxldsnta may pravenl 
~Iharoaslamrla by lnhlblllng llpld pemxldnllon. Slnoe there exist faw In vlvo 
sludlns en llpld psroxldatlon In CAD, we moaaumd dlftomnt parametera at 
llpld pwrexldallen (puroxldau, cnnjugated dlanaa and TSARS) In 100 CAD 
patlenta nnd campared them to 116 contml sublwte. AR axpactcad, CAD 
pallsnts had hlahar tdglyasrlde (lt%! VII 107 mgldl), total chol$staml (220 va 
1flD m@dl), L0t.G (14S va lE5 mQldl) and lower HBL-6 (36 VII 47 m@dl) 
value8 RB compared to ths aontml group, renpaatlvaty. All theas dllfsmncaa 
warn stntlstlcally highly slgnlllannt (p - 0,001) The moan concenlrntlan ot 
llpld pemxldoa In patlsnts with CAD waa 26.2 &dl, the moan cancfmlratlon al 
senjugnted dlnnaa was 14.7 rlgldl nnd tha mann aancentrntlnn ot TSARS was 
8.0 &dl. In oontmla than8 valuaa were 21 II, II,4 and 1 .S &dl mspsctwaly. 
Slgnllbant dlttamncaa worn obaervad In both can)ugated dlanaa and TSARS 
(pa O,Ol), but m-4 In pmxldaa. 
When WI dlvldsd tha SAD amup Ho patisn~s wAh stabla (n 9 64) nnd 
patlsnta with unstable (n = 41)) an@na, we taund slgnltlaantly hlghqr levela In 
ths tatter gmup. Pallfmta wlth unatabla anglna ware alao taund ta have a@ 
nltloantly lawer alpha taaophamlADt. lavola when campamd to both pakan~s 
wl~h aklbla an(ttna and contmle. 
In con&&on wa mpotl ham tnr tha Wil time thRI plasma llpld pomxldntlon 
pmduclw am lncmnsnd In ptI~tonln wllh unntobla nnglna. I1 might wall bo uaolul 
la add antlaxktanta such aa vltamln E to the drugs lhnl am curmnlly usod ,n 
the tmntmant at unatnbla nnglnn, 
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Coronary Pla uo Cam oaltlon, Macrophage 
InfIltratIon an Tlasus 8 P actor Content In Patlenta 
Wlth Diabetes Msllltus 
i+.R. Momno. A. Mumla. I.F. Palnclos, M. Loon. V. Bomardl. J. Lopez-C, 
J. Chosobro. V. Fustor. J.T. Fnllan. Masvlchusotts Qcncrat H~pirnf. 
Harvard Achcnl School. Boston. A*\ and Aqounf SInat Medtcal Center. hI: 
NY USA 
Mocmphagos and nssuo lnctor (TFI am associolod with cnstabWy 01 coronary 
nrtoly dlsonsa. To ovalunto tho composltlon of coronary dlabellc loslons 
wo perlormed qunntltatcvn compulorizod plnnlmoby on comnnry specimens 
obtained by coronary athamctomy 01 62 &Ions ot diabetics and compared 
lhen with 62 lesions ot non.dlabetlc pallants. Speclmons worn stalned with 
trichrama, KP-1. nnd TF anhbocty far evaluation ot collagen. fibrocellular 
tissue, llpld pool. macmphages. and TF respec~ely. All patients had unslable 
nnglna. 
- 
Collngon 246103 57 * 4 1.63 t 02 42 i 4 0006 
Flbrocollubr 091+ 02 19 t J 24103 41 t3 oom1 
LIpId pool 0.39 1 0.1 912 014,004 3t1 001 
Macmphqos 0.96, 0.2 22 t 3 0.55 * 0.1 12 t 2 OooOl 
n3sue Fnctor 1 94 h 0 3 35 f 5 1.99 i 0.4 4013 0.07 
TF in Collngan 0.62to2 51 it3 0.55 ;t 0.1 33 i 4 0.02 
TF I” Flbmmll (r.59 + 0 1 23 t 5 1.26 tO2 54 * 7 0.001 
TF I” Lwtd 0.53 * 0.1 19 * 5 016tol 612 003 
Conclusions: Compared wllh non-&abet&., coronary plaque tlssco from 
diabetics has a greater content ot collagen. lipid pool and macrophages and 
lower fibmcellular tissue. TF content is increased in collagen and in lipid pool 
suggesting a mom vulnerable coronary lesion with increased thrombogenicity 
atter plaque ruplure. 
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The Prognortlc Value of Cardiac MyolIn Llght 
Chalnr In Acute Irchemlc Syndromes - Results 
From TIMI 38 
A.Y. Fung, Y. Gawad, CR. Thompson. G. Jackawskl. R. Leltmnnn. 
EM. Antman, M.J. TanaalJevlc, J. Canner, 8. Thompson, E. Brnunw@d. 
Unlvors#y ol BrIf\sh Co/umb/a, Vancouver. BC, Canada 
B&ground; The datactlan at cardiac rpeoltlc myosln Ilght sham 1 (MLCl) In 
the amum nug~sata the praasnca al myaonrdial damn@ We evaluutti the 
pmgnoatia value ot thla marker at presentatlen iF 1.331 patienta BnmtteXJ In 
the TIMI 3S $tudy with unstabla angina or non-Q myocadat inlasbon (MI). 
Compansan WRB made wl~h ane~her Mochem@at marker, carU@c @pet?ttffi 
tropomn I (cTnl), which IS known ta provida prognoubc intorfnstiion. 
Results! Patienta wlth slavated MLCl level8 $?.!I n@mt at pruaentatmn 
ware mom likely to have adveras autcome by B week@. 






Patients with nan.0 MI ar electrmardrographlo ehan$er wem mom kkety 
ta have elevated MCCI lavela (p . 0.001). Atter adtuatmng tot basekna 
charadonstios. mullivadats analysis showed lhat MlCl was lndependantty 
pred~otive al dsalh. Far oath incmase at MLCt by t .O right.. the rmxtatii 
nsk increased by 32% (p . O.oQl ). Using a regresston anatys6 model that 
tamed in a@, STysegment depresston (vanabtes that am knewn to predr( 
death), and eequenually addmq in the P twochemtcal markers values. MN1 
wan taund to be predetcve 01 donth (p i 0.004). while cl’nl was not (p = NS). 
Conclwron: Elevated MLCl tovel at presentatton IS an 1-t pee 
dlctar at death in acute tschemlc syndromes It pertonnsd tavombty m n)m 
panson wllh cTnl 
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Cholesteml Fteductlon Rapldty Improves Endothetial 
Function After Acute Coronary Syndromes 
J. Dupu~s. J.-C. Tardll. P ThBmux. Montmaf Heart Inshtute. AtiHa?f. 
Quebec. Canada 
Bactigmurh% APhough long term benefits 01 cholostemt towenng are well 
established. short term ettects have not bean demonstrated so that Inttiahon 
01 therapy atter acute coronary syndromes is not cons~demd urgent Therapy 
IS otten delayed because hospital phase cholesterol “ay madequatety retbxt 
homeostasls. 
Methods. Pallents with myocarckal nlarctlon or unstable anpna and ad- 
misston total cholesterol -.5.2 or CDL -.3.4 were rardomlred to placebo (n 
= 30) or pravastalm 40 mg dally (n = 30) atter a mean 01 10 days (tune 0) 
for 6 weeks. Endolhekumdepandenl dllalalion was evaluated by measunng 
llow mediated dllatalmn (FMD) ot the brachial artery using htgh resolution 






641014 64 t 0.19 
FhtD 1%) 
PI‘XXLW PravaStatKl 
urn0 0 5e fO.16” 56iO22’ 545072 5O~OEl 
6 woks 63 t 0 lSt 4 9 * 0 24- 57tO81 7.0 i 0 79’ 
‘p. 005.“~. OO1vsndmlssmnandtp. 005.tp-OOlv~l~me0 
Values are mean f SEM. Responses to NTG were ldenltcal for both 
gmups at lime 0 and 6 weeks wllh an overall mean 018.6 f 0.56%. 
Conclusion: Patients with acute coronary syndmmes obtain a rapid ban- 
efit from cholesterol lowering by improving endothelial lunclmn. AdmIssion 
cholesteml is reliable and should be used to avoid delays in initialing Iherapy. 
